Snowball logo
logo
PSG

PharmaSGP Holding SE

PSG • XETRA
€28.80€0.00  (0%)
Estimate
P/E
17.1
EPS
1.68
Beta
-0.033
Forecast
P/E (FWD)
10.7
EPS (FWD)
2.7
About the company
Ticker
PSG
ISIN
DE000A2P4LJ5
Country
Germany
Sector (GICS)
Healthcare
PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve pain), headaches, and migraines; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels. It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness, and mood swings; Deruba, a cream for skin redness; Lentisol that prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. The company sells its products through pharmacies and wholesalers. It also exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

Frequently asked questions

What sector does PharmaSGP Holding SE (PSG) operate in?

PharmaSGP Holding SE belongs to the Healthcare sector and operates in the industry.

What is PharmaSGP Holding SE (PSG) current stock price?

As of the latest data, PharmaSGP Holding SE stock price is €28.80, with a previous close of €28.80.

What is PharmaSGP Holding SE (PSG) current market capitalization?

PharmaSGP Holding SE market cap is approximately 331.56 million.

What is PharmaSGP Holding SE (PSG) Earnings Per Share (EPS)?

The trailing EPS is €1.68, and the forward EPS is €2.70.

What is PharmaSGP Holding SE (PSG) Price-to-Earnings (P/E) ratio?

PharmaSGP Holding SE current P/E ratio is 17.14, with a forward P/E of 10.67.

Does PharmaSGP Holding SE (PSG) pay dividends?

No. PharmaSGP Holding SE does not pay a dividend.

What is PharmaSGP Holding SE (PSG) beta (volatility) score?

PharmaSGP Holding SE has a beta of -0.033, indicating lower volatility than the overall market.